71288-155 : Plerixafor 24 mg/1.2ml Subcutaneous Solution


NDC: 71288-155
Labeler: Meitheal Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Plerixafor
Dosage Form: Subcutaneous Solution
Application #: ANDA215698
Rev. Date: 


NDC Package Codes:

  • 71288-155-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (71288‑155‑01) / 1.2 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Plerixafor

Dosage Strength:

  • 24 mg/1.2mL

Pharmaceutical Classes:

  • Hematopoietic Stem Cell Mobilizer [EPC]
  • Increased Hematopoietic Stem Cell Mobilization [PE]

Related Products:

Based on records with the same trade name.
  • 0480-4320 Plerixafor 24 mg/1.2ml Subcutaneous Injection, Solution by Teva Pharmaceuticals, Inc.
  • 25021-416 Plerixafor 20 mg/ml Subcutaneous Injection, Solution by Sagent Pharmaceuticals
  • 43598-308 Plerixafor 24 mg/1.2ml Subcutaneous Solution by Dr. Reddy's Laboratories Inc
  • 55150-356 Plerixafor 24 mg/1.2ml Subcutaneous Solution by Eugia Us LLC
  • 65219-284 Plerixafor 24 mg/1.2ml Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
  • 68083-155 Plerixafor 24 mg/1.2ml Subcutaneous Injection, Solution by Gland Pharma Limited
  • 70121-1694 Plerixafor 24 mg/1.2ml Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
  • 70710-1208 Plerixafor 24 mg/1.2ml Subcutaneous Injection by Zydus Pharmaceuticals USA Inc.
  • 70771-1776 Plerixafor 24 mg/1.2ml Subcutaneous Injection by Zydus Lifesciences Limited
  • 72205-249 Plerixafor 24 mg/1.2ml Subcutaneous Injection, Solution by Novadoz Pharmaceuticals LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71288-155 QR Code

< Prev: 71288-153Next: 71288-156 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.